Measurements of cancer extent in a conservatively treated prostate cancer biopsy cohort.
about
Prognostic value of PTEN loss in men with conservatively managed localised prostate cancer.Optimal method for measuring tumor extent in needle biopsy specimens to identify small-volume prostate cancer.Variation in reporting of cancer extent and benign histology in prostate biopsies among European pathologists.
P2860
Measurements of cancer extent in a conservatively treated prostate cancer biopsy cohort.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Measurements of cancer extent in a conservatively treated prostate cancer biopsy cohort.
@en
Measurements of cancer extent in a conservatively treated prostate cancer biopsy cohort.
@nl
type
label
Measurements of cancer extent in a conservatively treated prostate cancer biopsy cohort.
@en
Measurements of cancer extent in a conservatively treated prostate cancer biopsy cohort.
@nl
prefLabel
Measurements of cancer extent in a conservatively treated prostate cancer biopsy cohort.
@en
Measurements of cancer extent in a conservatively treated prostate cancer biopsy cohort.
@nl
P2093
P2860
P50
P1433
P1476
Measurements of cancer extent in a conservatively treated prostate cancer biopsy cohort
@en
P2093
Christopher S Foster
Gabrielle Fisher
Jack Cuzick
Michael W Kattan
Peter Scardino
Ramzi Rajab
Transatlantic Prostate Group
Victor Reuter
P2860
P2888
P304
P356
10.1007/S00428-010-0971-Z
P577
2010-09-09T00:00:00Z